The following video is brought to you courtesy of the Bloomberg Markets and Finance YouTube Channel. Click the video below to watch it now.
Feb.14 — AstraZeneca Plc Chief Executive Officer Pascal Soriot discusses the Trump administration’s plan to lower U.S. drug costs by banning some payments to middlemen. He spoke after the Cambridge, England-based company forecast expanded earnings for the year, highlighting a rosy outlook for a slew of new products as the drugmaker turns into a cancer powerhouse. Soriot also discusses Brexit planning in an interview with Bloomberg’s Annmarie Hordern.